HR 1192 RFS 
‘‘(F) National experts in the duties listed 
under subsection (c). 
‘‘(G) Health care providers furnishing 
services to a patient population that consists of 
a high percentage (as specified by the Sec-
retary) of individuals who are enrolled in a 
State plan under title XIX of the Social Secu-
rity Act or who are not covered under a health 
plan or health insurance coverage. 
‘‘(3) CHAIRPERSON.—The voting members of 
the Commission shall select a chairperson from the 
members appointed under paragraph (2) from the 
category under paragraph (2)(A). 
‘‘(4) MEETINGS.—The Commission shall meet 
at least twice, and not more than four times, a year. 
‘‘(5) BOARD TERMS.—Members of the Commis-
sion appointed pursuant to subparagraph (B) or (C) 
of paragraph (1), including the chairperson, shall 
serve for a 3-year term. A vacancy on the Commis-
sion shall be filled in the same manner as the origi-
nal appointments. 
‘‘(c) DUTIES.—The Commission shall— 
‘‘(1) evaluate programs of the Department of 
Health and Human Services regarding the utiliza-
tion of diabetes screening benefits, annual wellness 
VerDate Sep 11 2014 
22:37 Nov 15, 2016
Jkt 069200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H1192.RFS
H1192
sradovich on DSK3GMQ082PROD with BILLS
HR 1192 RFS 
visits, and other preventive health benefits that may 
reduce the incidence of the diseases and complica-
tions described in subsection (a), including explain-
ing problems regarding such utilization and related 
data collection mechanisms; 
‘‘(2) identify current activities and critical gaps 
in Federal efforts to support clinicians in providing 
integrated, high-quality care to individuals with any 
of the diseases and complications described in sub-
section (a); 
‘‘(3) make recommendations regarding the co-
ordination of clinically-based activities that are being 
supported by the Federal Government with respect 
to the diseases and complications described in sub-
section (a); 
‘‘(4) make recommendations regarding the de-
velopment and coordination of federally funded clin-
ical practice support tools for physicians and other 
health care professionals in caring for and managing 
the care of individuals with any of the diseases and 
complications described in subsection (a), specifically 
with regard to implementation of new treatments 
and technologies; 
‘‘(5) evaluate programs described in subsection 
(a) that are in existence as of the date of the enact-
VerDate Sep 11 2014 
22:37 Nov 15, 2016
Jkt 069200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H1192.RFS
H1192
sradovich on DSK3GMQ082PROD with BILLS
HR 1192 RFS 
ment of this section and determine if such programs 
are meeting the needs identified in paragraph (2) 
and, if such programs are determined as not meet-
ing such needs, recommend programs that would be 
more appropriate; 
‘‘(6) recommend, with respect to the diseases 
and complications described in subsection (a), clin-
ical pathways for new technologies and treatments, 
including future data collection activities, that may 
be developed and then used to evaluate— 
‘‘(A) various care models and methods; 
and 
‘‘(B) the impact of such models and meth-
ods on quality of care as measured by appro-
priate care parameters (such as A1C, blood 
pressure, and cholesterol levels); 
‘‘(7) evaluate and expand education and aware-
ness activities provided to physicians and other 
health care professionals regarding clinical practices 
for the prevention of the diseases and complications 
described in subsection (a); 
‘‘(8) review and recommend appropriate meth-
ods for outreach and dissemination of educational 
resources that— 
VerDate Sep 11 2014 
22:37 Nov 15, 2016
Jkt 069200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H1192.RFS
H1192
sradovich on DSK3GMQ082PROD with BILLS
HR 1192 RFS 
‘‘(A) regard the diseases and complications 
described in subsection (a); 
‘‘(B) are funded by the Federal Govern-
ment; and 
‘‘(C) are intended for health care profes-
sionals and the public; and 
‘‘(9) carry out other activities, such as activities 
relating to the areas of public health and nutrition, 
that the Commission deems appropriate with respect 
to the diseases and complications described in sub-
section (a). 
‘‘(d) OPERATING PLAN.— 
‘‘(1) INITIAL PLAN.—Not later than 90 days 
after its first meeting, the Commission shall submit 
to the Secretary and the Congress an operating plan 
for carrying out the activities of the Commission as 
described in subsection (c). Such operating plan may 
include— 
‘‘(A) a list of specific activities that the 
Commission plans to conduct for purposes of 
carrying out the duties described in each of the 
paragraphs in subsection (c); 
‘‘(B) a plan for completing the activities; 
‘‘(C) a list of members of the Commission 
and other individuals who are not members of 
VerDate Sep 11 2014 
22:37 Nov 15, 2016
Jkt 069200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H1192.RFS
H1192
sradovich on DSK3GMQ082PROD with BILLS
HR 1192 RFS 
the Commission who will need to be involved to 
conduct such activities; 
‘‘(D) an explanation of Federal agency in-
volvement and coordination needed to conduct 
such activities; 
‘‘(E) a budget for conducting such activi-
ties; 
‘‘(F) a plan for evaluating the value and 
potential impact of the Commission’s work and 
recommendations, including the possible con-
tinuation of the Commission for the purposes of 
overseeing their implementation; and 
‘‘(G) other information that the Commis-
sion deems appropriate. 
‘‘(2) UPDATES.—The Commission shall periodi-
cally update the operating plan under paragraph (1) 
and submit such updates to the Secretary and the 
Congress. 
‘‘(e) FINAL REPORT.—By not later than 3 years after 
the date of the Commission’s first meeting, the Commis-
sion shall submit to the Secretary and the Congress a final 
report containing all of the findings and recommendations 
required by this section. Not later than 120 days after 
the submission of the final report, the Secretary shall re-
view the plan required by subsection (d)(1)(F) and submit 
VerDate Sep 11 2014 
22:37 Nov 15, 2016
Jkt 069200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H1192.RFS
H1192
sradovich on DSK3GMQ082PROD with BILLS
HR 1192 RFS 
to the Congress a recommendation on whether the Com-
mission should be reauthorized to operate after fiscal year 
2019. 
‘‘(f) SUNSET.—The Commission shall terminate at 
the end of fiscal year 2019.’’. 
Passed the House of Representatives November 14, 
2016. 
Attest: 
KAREN L. HAAS, 
Clerk. 
VerDate Sep 11 2014 
22:37 Nov 15, 2016
Jkt 069200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\H1192.RFS
H1192
sradovich on DSK3GMQ082PROD with BILLS